CCT New
  • Home
  • Services
    • Revalo Health >
      • Value for Providers
      • Value for Life Science & Med-Tech
      • Value for Payers
    • Real-World Evidence
  • Platform
    • Connected Technologies Platform
    • Revalo Federated Query System
    • Revalo Staging System
    • Portal Login
  • About Us
    • Mission & Awards
    • Press Releases
    • History
    • Executive Team
    • Board of Directors
  • Global
  • Contact
  • Portal Login
  • English ►
    • 日本語
    • Taiwan
  • Home
  • Services
    • Revalo Health >
      • Value for Providers
      • Value for Life Science & Med-Tech
      • Value for Payers
    • Real-World Evidence
  • Platform
    • Connected Technologies Platform
    • Revalo Federated Query System
    • Revalo Staging System
    • Portal Login
  • About Us
    • Mission & Awards
    • Press Releases
    • History
    • Executive Team
    • Board of Directors
  • Global
  • Contact
  • Portal Login
  • English ►
    • 日本語
    • Taiwan

China Case Study

In China, Convergence CT has developed nearly 11,000 reporting measures for hospitals seeking Ministry of Health Level III accreditation.

Reporting Measures Developed for Hospitals in China:

Quality

  • Mortality
  • Infection control
  • Re-admissions
  • Surgical complications
  • Repeat surgeries
  • Falls
  • Bed sores
  • ER triage accuracy

Performance

  • Patient volume
  • Patient pathways
  • Length of stay
  • Surgeries
  • Interventional diagnostics & procedures
  • Emergency room operations
  • Clinic operations

Financial

Costs related to:
  • Medicines
  • Treatments
  • Visits
  • Patient days

Financial information:
  • Income
  • Expenses
  • Financial ratios
  • Asset utilization

Cardiatric Specialty Analytics

At one cardiatric specialty hospital in the city of Wuhan, in addition to the nearly 11,000 reporting measures to satisfy China's Ministry of Health Level III accreditation, CCT generates clinical analytics specialized for cardiovascular diseases. This makes it possible to analyze the performance of therapies and improve the level of care.

Combining analytics on cardiovascular diseases with other hospital programs supports sponsored research on a global scale. These global analytics can be used for clinical trials, outcome studies, and value analytics.

Home

About

Services

Contact

Copyright © 2020